Stockscreener 앱 받기
363.07
1.09%
-4.285
전일 마감가:
$367.36
열려 있는:
$366.6
하루 거래량:
107.07K
Relative Volume:
0.35
시가총액:
$16.40B
수익:
$2.76B
순이익/손실:
$1.11B
주가수익비율:
15.95
EPS:
22.77
순현금흐름:
$898.10M
1주 성능:
-1.95%
1개월 성능:
-1.25%
6개월 성능:
+3.34%
1년 성능:
+65.78%
1일 변동 폭
$362.00
$369.00
1주일 범위
$362.00
$383.50
52주 변동 폭
$214.75
$417.81
유나이티드 테라퓨틱스 Stock (UTHR) Company Profile
명칭
United Therapeutics Corp
전화
(301) 608-9292
주소
1000 SPRING ST, SILVER SPRING, MD
UTHR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
362.12 | 16.40B | 2.76B | 1.11B | 898.10M | 22.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
480.75 | 123.34B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
696.56 | 76.09B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
648.35 | 39.34B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.00 | 32.49B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
116.91 | 28.26B | 3.30B | -501.07M | 1.03B | -2.1146 |
유나이티드 테라퓨틱스 Stock (UTHR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-02-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2022-12-06 | 개시 | UBS | Buy |
| 2022-12-05 | 개시 | Goldman | Sell |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2022-09-20 | 재확인 | BofA Securities | Underperform |
| 2022-09-19 | 재개 | Wedbush | Outperform |
| 2022-02-11 | 개시 | BTIG Research | Neutral |
| 2021-07-14 | 업그레이드 | Argus | Hold → Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-02-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-06-25 | 재확인 | H.C. Wainwright | Neutral |
| 2020-03-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-02-27 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-01-31 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 개시 | BofA/Merrill | Underperform |
| 2019-08-01 | 업그레이드 | Jefferies | Underperform → Hold |
| 2019-08-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-09 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2018-08-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 재확인 | Barclays | Underweight |
| 2018-01-18 | 재개 | Credit Suisse | Underperform |
| 2017-12-27 | 재확인 | Wedbush | Outperform |
| 2017-04-27 | 재확인 | Wedbush | Outperform |
| 2017-03-30 | 개시 | UBS | Sell |
| 2017-03-16 | 개시 | Credit Suisse | Underperform |
모두보기
유나이티드 테라퓨틱스 주식(UTHR)의 최신 뉴스
United Therapeutics Co. (NASDAQ:UTHR) COO Sells $3,710,500.00 in Stock - MarketBeat
New York State Teachers Retirement System Lowers Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (UTHR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Allspring Global Investments Holdings LLC Cuts Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
AustralianSuper Pty Ltd Buys 161,751 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Quent Capital LLC Sells 3,232 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (UTHR) Projected to Post Earnings on Wednesday - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Empirical Finance LLC - MarketBeat
United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN
Empowered Funds LLC Lowers Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength? - Yahoo Finance
United Therapeutics' president sells shares worth $3.48 million - MSN
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) COO Sells 10,000 Shares of Stock - MarketBeat
United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now - Insider Monkey
United Therapeutics' president sells shares worth $3.48 million By Investing.com - Investing.com Australia
Livforsakringsbolaget Skandia Omsesidigt Has $9.90 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics’ president sells shares worth $3.48 million By Investing.com - Investing.com Nigeria
United Therapeutics Corp. to Host Earnings Call - ACCESS Newswire
Polaris Capital Management LLC Decreases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (NASDAQ:UTHR) Sees Strong Trading VolumeWhat's Next? - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Holdings Lowered by Tobam - MarketBeat
United Therapeutics president sells $3.5m in stock - MSN
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial - Dallas Business Journal
State Street Corp Reduces Stake in United Therapeutics Corp - GuruFocus.com
UTHRUnited Therapeutics Corp Latest Stock News & Market Updates - StockTitan
United Therapeutics president sells $3.5m in stock By Investing.com - Investing.com Australia
China Universal Asset Management Co. Ltd. Purchases 909 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
FDA approves pig organ transplant trials for patients with kidney failure - The Washington Post
United Therapeutics Corporation's (NASDAQ:UTHR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
US FDA greenlights clinical trails for pig kidney transplants in humans - MSN
Breakthrough IPF Treatment Study Hits Key Milestone: 598 Patients Enrolled in Game-Changing Tyvaso Trial - StockTitan
US approves trials for pig kidney transplants in humans - NewsBytes
Short Interest in United Therapeutics Co. (NASDAQ:UTHR) Declines By 14.3% - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Stock Holdings Raised by Janney Montgomery Scott LLC - MarketBeat
United Therapeutics (NASDAQ:UTHR) Stock Price Down 4.9%Here's What Happened - MarketBeat
유나이티드 테라퓨틱스 (UTHR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
유나이티드 테라퓨틱스 주식 (UTHR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 18 '25 |
Sale |
371.05 |
10,000 |
3,710,499 |
0 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 10 '25 |
Option Exercise |
111.00 |
10,000 |
1,110,000 |
7,500 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Feb 10 '25 |
Sale |
348.06 |
10,000 |
3,480,642 |
0 |
| MAHON PAUL A | EVP & GENERAL COUNSEL |
Feb 06 '25 |
Option Exercise |
163.30 |
7,700 |
1,257,410 |
44,410 |
0.28%
0.42%
자본화:
|
볼륨(24시간):